Patent Assignment
Reel/Frame 044523/0160
Merger and Change of Name
Recorded: 2018-01-03
Pages: 5
Assignors
AMAG PHARMACEUTICALS IP, LTD.
Executed: 2017-12-21
AMAG PHARMA USA, INC.
Executed: 2017-12-21
Assignee
AMAG PHARMA USA, INC.
1100 WINTER STREET, WALTHAM, MASSACHUSETTS, 02451
Covered Properties
(15)
Maximizing Effectiveness of Substances Used to Improve Health and Well Being
Patent:
5,945,123 →
Application:
09/053,487 →
Folic Acid Supplement
Patent:
6,261,600 →
Application:
09/303,000 →
Dietary Supplement
Patent:
6,569,857 →
Application:
09/303,689 →
Anti-Nausea Compositions and Methods
Patent:
6,197,329 →
Application:
09/303,690 →
Maximizing Effectiveness of Substances Used to Improve Health and Well Being
Patent:
6,214,379 →
Application:
09/323,158 →
Nutritional Supplements
Patent:
6,258,846 →
Application:
09/323,159 →
Strip Pack
Patent:
6,375,956 →
Application:
09/358,540 →
Formulation for Menopausal Women
Patent:
6,479,545 →
Application:
09/409,059 →
Nutritional Composition
Patent:
6,352,713 →
Application:
09/451,849 →
Composition with Sustained Release of Levodopa and Carbidopa
Nutritional Supplements
Formulation for Menopausal Women
Nutritional Supplements
Rapidly Disintegrable Tablets
Patent:
7,282,217 →
Application:
10/929,856 →
Methods for Reducing the Occurrence of Preterm Delivery and Other Pregnancy-Related Conditions
Application:
15/147,500 →
Publication:
US 2017/0087165
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Sep 17, 2013
From: DRUGTECH CORPORATION
To: LAW DEBENTURE TRUST COMPANY OF NEW YORK, AS AGENT
Reel/Frame 031226/0883 →
Change of Name
Jul 9, 2014
From: DRUGTECH CORPORATION
To: LUMARA HEALTH IP LTD.
Reel/Frame 033282/0265 →
Assignment of Assignor's Interest
Jul 9, 2014
From: KV PHARMACEUTICAL COMPANY
To: DRUGTECH CORPORATION
Reel/Frame 033269/0474 →
Assignment of Assignor's Interest
Jul 9, 2014
From: K-V PHARMACEUTICAL COMPANY
To: DRUGTECH CORPORATION
Reel/Frame 033269/0301 →
Assignment of Assignor's Interest
Jul 9, 2014
From: LEVINSON, R. SAUL; HERMELIN, MARC S.; KIRSCHNER, MITCHELL I.
To: KV PHARMACEUTICAL COMPANY
Reel/Frame 033269/0253 →
Assignment of Assignor's Interest
Jul 9, 2014
From: HERMELIN, VICTOR M.
To: KV PHARMACEUTICAL COMPANY
Reel/Frame 033269/0393 →
Release of Security Interests in Intellectual Property
Oct 20, 2014
From: LAW DEBENTURE TRUST COMPANY OF NEW YORK
To: K-V PHARMACEUTICAL COMPANY
Reel/Frame 034018/0040 →
Security Interest
Nov 12, 2014
From: LUMARA HEALTH IP LTD
To: JEFFERIES FINANCE LLC
Reel/Frame 034156/0243 →
Security Interest
Sep 25, 2015
From: LUMARA HEALTH IP LTD.
To: JEFFERIES FINANCE LLC
Reel/Frame 036653/0138 →
Release of Security Interest
Oct 1, 2015
From: WILLMINGTON TRUST, NATIONAL ASSOCIATION
To: LUMARA HEALTH IP LTD
Reel/Frame 036704/0822 →
Release of Security Interest
Oct 9, 2015
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: LUMARA HEALTH IP LTD.
Reel/Frame 036763/0475 →
Release of Security Interest
May 15, 2017
From: JEFFERIES FINANCE LLC
To: LUMARA HEALTH IP LTD.
Reel/Frame 042461/0626 →
Assignment of Assignor's Interest
Dec 26, 2017
From: LEE, CHANG; BIRCH, ROBERT
To: DRUGTECH CORPORATION
Reel/Frame 044484/0627 →
Change of Name
Dec 27, 2017
From: DRUGTECH CORPORATION
To: LUMARA HEALTH IP LTD.
Reel/Frame 044961/0257 →
Change of Name
Dec 27, 2017
From: LUMARA HEALTH IP LTD.
To: AMAG PHARMACEUTICALS IP, LTD.
Reel/Frame 044961/0232 →
Change of Name
Jan 2, 2018
From: LUMARA HEALTH IP LTD.
To: AMAG PHARMACEUTICALS IP, LTD.
Reel/Frame 044996/0645 →
Assignment of Assignor's Interest
Feb 12, 2021
From: AMAG PHARMA USA, INC.
To: COVIS PHARMA GMBH
Reel/Frame 055241/0119 →
Security Interest
Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Corrective Assignment to Correct the Receiving Party's Address Previously Recorded at Reel: 055241 Frame: 0119. Assignor(S) Hereby Confirms the Assignment.
Feb 23, 2021
From: AMAG PHARMA USA, INC.
To: COVIS PHARMA GMBH
Reel/Frame 055363/0561 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →